Product Information
HYDROXYZINE PAM 50 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0822 per EA under NDC 00555030204. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Hydroxyzine Pamoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555030204
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA088487On Market Since
7/1/1984
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 50 MG CAP has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0822 per EA |
|---|---|
| All-time high | $0.1088 (Jul 12, 2023) |
| All-time low | $0.0683 (Apr 17, 2024) |
| 52-week high | $0.0851 |
| 52-week low | $0.0796 |
| Median price | $0.0806 |
| Average price | $0.0827 |
| Largest weekly change | +16.5% (Jan 22, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 50 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.0822 per EA (NDC 00555030204), effective Jun 24, 2026.
How has the price of HYDROXYZINE PAM 50 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 50 MG CAP has risen 5.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 50 MG CAP?
Since Nov 28, 2013, the NADAC for HYDROXYZINE PAM 50 MG CAP has ranged from a low of $0.0683 (Apr 17, 2024) to a high of $0.1088 (Jul 12, 2023), with a median of $0.0806 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 50 MG CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROXYZINE PAM 50 MG CAP, but none are currently priced below it.
Who manufactures HYDROXYZINE PAM 50 MG CAP?
HYDROXYZINE PAM 50 MG CAP (NDC 00555030204) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification